|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.84 USD | -2.56% |
|
-15.92% | +14.77% |
| 07-24 | Wedbush Adjusts Price Target on NovoCure to $20 From $18, Maintains Neutral Rating | MT |
| 07-23 | NovoCure Limited, Q2 2026 Earnings Call, Jul 23, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.56% | -15.92% | -2.05% | -2.43% | +14.77% | +28.26% | -54.53% | -90.36% | +97.34% | 1.73B | |
| +0.43% | +0.77% | +1.72% | -1.62% | +3.31% | +27.32% | +5.88% | +20.64% | +370.19% | 12.65B | |
| +0.55% | +3.08% | +19.84% | +29.34% | +8.50% | +22.94% | +21.03% | -36.54% | +36.83% | 6.78B | |
| -0.80% | +6.33% | -5.45% | +8.94% | +22.31% | +51.96% | +23.13% | +21.47% | +202.89% | 5.98B | |
| -0.52% | +7.25% | +20.74% | +46.27% | - | - | - | - | - | 5.07B | |
| +3.47% | +9.59% | +25.25% | -4.40% | -6.52% | -20.08% | +40.17% | +7.96% | - | 4.75B | |
| +0.32% | +5.56% | +9.43% | -4.10% | -26.51% | -19.50% | -16.92% | -17.63% | +25.73% | 4.15B | |
| +0.32% | +5.10% | +0.82% | +35.68% | +23.35% | -20.67% | +225.26% | -41.70% | - | 1.84B | |
| +1.27% | -0.82% | +1.51% | +9.25% | +53.21% | +55.08% | -7.33% | +33.58% | +157.57% | 1.58B | |
| +2.67% | +6.90% | +2.67% | -22.68% | -22.85% | -27.30% | -50.78% | -68.81% | - | 1.27B | |
| -0.32% | +6.19% | +19.44% | +35.19% | -37.08% | -14.51% | -4.84% | -56.91% | +1,176.11% | 1.16B | |
| -1.28% | +6.86% | +8.82% | +43.34% | -9.94% | +4.29% | -31.06% | -41.46% | - | 788M | |
| +1.21% | +7.63% | +4.68% | -33.60% | -35.42% | -41.67% | -46.75% | -70.32% | - | 776M | |
| -0.11% | +2.51% | -5.41% | +22.37% | -2.86% | +182.26% | +22.96% | -42.49% | +150.18% | 635M | |
| -6.71% | +15.11% | +84.97% | +126.15% | +269.94% | +383.02% | +454.11% | -6.98% | - | 436M | |
| +1.07% | +4.12% | +3.27% | -11.45% | -26.12% | -9.55% | +7.37% | +15.90% | -62.14% | 451M | |
| +4.91% | +7.12% | -8.51% | -10.81% | -7.08% | -12.48% | -34.16% | -18.18% | - | 464M | |
| +2.96% | +25.74% | +21.29% | -15.84% | -17.26% | -26.86% | +34.11% | +14.29% | - | 428M | |
| -0.29% | -4.55% | -2.39% | -13.27% | -12.61% | -1.56% | +34.56% | - | - | 367M | |
| +2.15% | +4.22% | -6.98% | -21.86% | -12.27% | -20.09% | -51.69% | - | - | 370M | |
| Average | +0.44% | +3.29% | +9.68% | +10.72% | +9.41% | +28.47% | +30.03% | -22.21% | +239.41% | 2.58B | |
| Weighted average by Cap. | +0.43% | +3.45% | +8.93% | +10.91% | +4.76% | +19.46% | +18.48% | -7.38% | +230.68% |
- Stock Market
- Stocks
- NVCR Stock
- Sector NovoCure Limited
Select your edition
All financial news and data tailored to specific country editions
